CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 132 enrolled
Drug / intervention
ASTRA TECH Implant System, OsseoSpeed™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00710944
NCT00710944N/ACompleted
CompareCT.gov

An Open, Prospective, Controlled Study in the Maxilla to Evaluate Clinical Outcome of ASTRA TECH Implant System, OsseoSpeed™ Implants in Single Tooth Replacement Using an Immediate Loading Protocol in Extraction Sockets and Healed Ridges.

Dentsply Sirona Implants and Consumables·interventional·Posted Jul 8, 2008·Updated Jul 11, 2014

In Brief

A clinical study evaluating ASTRA TECH Implant System, OsseoSpeed™ for Jaw, Edentulous, Partially. Completed, enrolled 132 participants across 4 sites in 4 countries.

Detailed Summary

The purpose of this study is to evaluate survival for ASTRA TECH Implant System, OsseoSpeed™ implants following immediate loading in extraction sockets versus immediate loading in healed ridges. Patients in need of single standing implants replacing teeth in the maxilla within zone 15-25 will be included and followed for 5 years. Primary objective is implant survival rate at 12 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsJaw, Edentulous, Partially
CountriesBelgium, Germany, Spain, United States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 8, 2008
Enrollment StartApr 1, 2005
Primary CompletionJun 1, 2008
Study CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 18.0 years ago

Interventions

ASTRA TECH Implant System, OsseoSpeed™device

ASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.